KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evertec (EVTC) Income from Continuing Operations (2016 - 2025)

Evertec has reported Income from Continuing Operations over the past 14 years, most recently at 37036000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 37036000.0 for Q4 2025, down 8.93% from a year ago — trailing twelve months through Dec 2025 was 144560000.0 (up 25.95% YoY), and the annual figure for FY2025 was 144560000.0, up 25.95%.
  • Income from Continuing Operations for Q4 2025 was 37036000.0 at Evertec, up from 33460000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for EVTC hit a ceiling of 137739000.0 in Q3 2022 and a floor of 9956000.0 in Q3 2023.
  • Median Income from Continuing Operations over the past 5 years was 33508000.0 (2022), compared with a mean of 36961350.0.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 290.64% in 2022 and later crashed 92.77% in 2023.
  • Evertec's Income from Continuing Operations stood at 41188000.0 in 2021, then tumbled by 30.3% to 28708000.0 in 2022, then crashed by 58.87% to 11807000.0 in 2023, then surged by 244.43% to 40667000.0 in 2024, then decreased by 8.93% to 37036000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 37036000.0 (Q4 2025), 33460000.0 (Q3 2025), and 40973000.0 (Q2 2025) per Business Quant data.